Streetbeat News

Products Services

MBOT

Microbot Medical has achieved 50% enrollment in its pivotal clinical trial for the LIBERTY Endovascular Robotic Surgical System. The company anticipates full enrollment and a 510(k) FDA submission by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:34 pm

INMB

INmune Bio Inc. announced positive results from an interim analysis of its Phase 2 Alzheimer's Disease trial, showing a strong correlation between the novel cognitive measure EMACC and the established CDR-SB endpoint.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:34 pm

CRKN

Crown Electrokinetics Corp. (NASDAQ:CRKN) reiterates its Q3 revenue guidance of $8 million, marking a 70% sequential increase. The company also reports progress in its Film Division, particularly in mastering technology for Dynamic Tint™ film.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:33 pm

BNZI

Banzai International reported the addition of 179 new customers in August, indicating potential growth and increased market penetration.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:33 pm

LUCY

Innovative Eyewear is set to unveil its ANSI-certified smart safety eyewear at the Vision Expo West from September 19-21. This new product launch could enhance the company's market position in the smart eyewear segment.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:33 pm

WATT

Energous has shipped its first 2W PowerBridge transmitter orders to a Fortune 100 tech company. This development is aimed at enhancing asset tracking through wireless power networks, specifically for reverse logistics.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:32 pm

DDD

3D Systems has received FDA clearance for its Monolithic Jetted Denture solution, a significant milestone in the dental industry. This approval allows the company to market its innovative denture solution in the United States, potentially boosting its market presence and revenue.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:31 pm

VRNA

Verona Pharma partners with Ritedose to deliver Ohtuvayre, a novel COPD drug. This partnership marks the introduction of the first inhaled product with a new mechanism for COPD treatment in over 20 years.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:31 pm

AVGO

NVDA

Jim Cramer expressed strong support for Broadcom (AVGO), highlighting its AI advancements and reasonable valuation compared to Nvidia (NVDA). Broadcom's stock has rebounded after a post-earnings dip, and Nancy Pelosi's investment in Broadcom options adds interest. The stock is up 48% this year.

Portfolio Pulse from Shanthi Rexaline

September 17, 2024 | 12:18 pm

VLN

Valens Semiconductor (NYSE:VLN) has secured three automotive design wins from leading European OEMs for its VA7000 MIPI A-PHY chipsets, expected to generate over $10 million annually starting in 2026. This strengthens Valens' position in ADAS connectivity solutions.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 12:17 pm